Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
about
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolitesEuropean Myeloma Network guidelines for the management of multiple myeloma-related complications.Salvage therapy of multiple myeloma: the new generation drugs.Bendamustine in multiple myeloma.Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an updateBendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study.Bortezomib for the treatment of multiple myeloma.Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.The role of bendamustine in the management of plasma cell myeloma.
P2860
Q27011795-68E82E7C-8FE7-4D04-B461-4E7BD072FC45Q36115636-F2185DC5-EBF2-466D-8771-731BB8246C71Q38223433-3C26F594-5768-473A-B680-018A51330313Q38530583-DB8A6ADD-56F3-41E4-9193-4DBA2DFD0925Q38548134-9F588342-6FBA-4DAA-9654-703BC25B23C3Q38642648-B4B0C5ED-13FE-41E3-AF7D-19A545FC5283Q38700745-A238069D-AEBC-4815-8213-58C15DA2DCB5Q38896793-EA9CEA7E-29F4-4D12-947D-202C0575E54FQ40299548-69FEA284-9A69-44CC-B866-93BA8ECACDE4Q47604607-BEB1D18C-9510-4D78-9A96-F09854D9E728Q52958098-9C000F1A-A3F7-4D4F-ABC6-1AB941C0333AQ53008511-162944FE-FA1D-4A27-B42F-1022639452BC
P2860
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Bendamustine and prednisone in ...... t chain-induced renal failure.
@en
Bendamustine and prednisone in combination with bortezomib
@nl
type
label
Bendamustine and prednisone in ...... t chain-induced renal failure.
@en
Bendamustine and prednisone in combination with bortezomib
@nl
prefLabel
Bendamustine and prednisone in ...... t chain-induced renal failure.
@en
Bendamustine and prednisone in combination with bortezomib
@nl
P2093
P2860
P1476
Bendamustine and prednisone in ...... t chain-induced renal failure.
@en
P2093
Andreas Schwarzer
Anette Bachmann
Barbara Moll
Cornelia Becker
Dietger Niederwieser
Franz Albert Hoffmann
Lorenz Weidhase
Malvina Bourgeois
Marc Andrea
Marion Schmalfeld
P2860
P2888
P304
P356
10.1007/S00432-013-1513-2
P577
2013-09-18T00:00:00Z
P6179
1011150943